Tuesday - November 4, 2025

B-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibiting Peptidomimetics

2025-09-16

ALEXANDRIA, Virginia, Sept. 16 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC., Tampa, Florida has been assigned a patent (No. US 12415832 B2, initially filed April 24, 2020) developed by five inventors Jianfeng Cai, Tampa, Florida; Peng Sang, Tampa, Florida; Yan Shi, Tampa, Florida; Haitao Ji, Tampa, Florida; and Min Zhang, Tampa, Florida, for "B-catenin/B-cell Lymphoma 9 protein-protein interaction inhibiting peptidomimetics." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

B-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibiting Peptidomimetics

Information Request Form

Copyright Targeted News Service 2025